Abstract:Jie Li, 1– 4 Jiaqian Zhao, 2– 5 Tiantian Tan, 2– 4 Mengmeng Liu, 2– 4 Zhaowu Zeng, 2– 4 Yiying Zeng, 2– 4 Lele Zhang, 6 Chaomei Fu, 1 Dajing Chen, 2– 4 Tian Xie 2– 4 1 College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People's Republic of China; 2 Holistic Integrative Pharmacy Institutes, Hangzhou Normal University, Hangzhou, Zhejiang, People's Republic of China; 3 Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China; 4 Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China; 5 College of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China; 6 School of Medicine, Chengdu University, Chengdu, People's Republic of China Correspondence: Tian Xie; Zhaowu Zeng Holistic Integrative Pharmacy Institutes, Hangzhou Normal University, 1378 Wenyixi Road, Hangzhou, Zhejiang 311121, People's Republic of China Tel +86 5 712 886 8269 Email xbs@dljg.sina.net; artgreenking@126.com Gliomas are the most common tumor of the central nervous system. However, the presence of the brain barrier blocks the effective delivery of drugs and leads to the treatment failure of various drugs. The development of a nanoparticle drug delivery system (NDDS) can solve this problem. In this review, we summarized the brain barrier (including blood–brain barrier (BBB), blood–brain tumor barriers (BBTB), brain–cerebrospinal fluid barrier (BCB), and nose-to-brain barrier), NDDS of glioma (such as passive targeting systems, active targeting systems, and environmental responsive targeting systems), and NDDS efficacy improvement strategies and deficiencies. The research prospect of drug-targeted delivery systems for glioma is also discussed. Keywords: glioma, brain barrier, nanoparticle drug delivery system, efficacy improvement strategies, deficiencies of NDDS

Erratum: Differential Geometry Perspective of Shape Coherence and Curvature Evolution by Finite-Time Nonhyperbolic Splitting

Novel Nano-Drug Delivery System for Brain Tumor Treatment

Recent advances in drug delivery systems for targeting brain tumors

Targeted Regulation of Blood-Brain Barrier for Enhanced Therapeutic Efficiency of Hypoxia-Modifier Nanoparticles and Immune Checkpoint Blockade Antibodies for Glioblastoma

Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy (small 45/2022)

Noninvasive Nanoparticle Strategies for Brain Tumor Targeting.

Recent Advances in Brain Tumor-Targeted Nano-Drug Delivery Systems

Functionalized nanoparticles crossing the brain–blood barrier to target glioma cells

Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System

The Nanocarrier Strategy for Crossing the Blood-Brain Barrier in Glioma Therapy

Misuse of Cortisone Eyedrops.

Research Advances in Brain-Targeted Nanoscale Drug Delivery System

Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment

Brain-targeted nanoparticle drug delivery systems:research advances

Nanomaterials for Diagnosis and Treatment of Brain Cancer: Recent Updates

Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review

Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises

Microfluidics‐Prepared Ultra‐small Biomimetic Nanovesicles for Brain Tumor Targeting

Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology

Ultrasound-assisted brain delivery of nanomedicines for brain tumor therapy: advance and prospect

Brain tumor-targeted drug delivery strategies